2015
DOI: 10.1016/s0960-9776(15)70351-6
|View full text |Cite
|
Sign up to set email alerts
|

P321 Analgesia with thoracic wall nerve block for breast reconstruction with expander or implant

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(4 citation statements)
references
References 0 publications
2
2
0
Order By: Relevance
“…In addition, there was significant variability in the regimen used, making it impossible to draw conclusions regarding optimal duration of anticoagulation. Despite this, the studies included in our review did point to a benefit of prophylactic enoxaparin in reducing venous thromboembolism without increasing the risk of hematoma formation 49,52,54,55 . These findings are in keeping with the larger VTEPS study, which examined thromboembolic events in a variety of plastic surgery procedures and concluded that postoperative, inpatient enoxaparin decreases 60-day rates of symptomatic thromboembolic events without significantly affecting hematoma rates 67 .…”
Section: Discussionsupporting
confidence: 63%
See 3 more Smart Citations
“…In addition, there was significant variability in the regimen used, making it impossible to draw conclusions regarding optimal duration of anticoagulation. Despite this, the studies included in our review did point to a benefit of prophylactic enoxaparin in reducing venous thromboembolism without increasing the risk of hematoma formation 49,52,54,55 . These findings are in keeping with the larger VTEPS study, which examined thromboembolic events in a variety of plastic surgery procedures and concluded that postoperative, inpatient enoxaparin decreases 60-day rates of symptomatic thromboembolic events without significantly affecting hematoma rates 67 .…”
Section: Discussionsupporting
confidence: 63%
“…this, the studies included in our review did point to a benefit of prophylactic enoxaparin in reducing venous thromboembolism without increasing the risk of hematoma formation. 49,52,54,55 These findings are in keeping with the larger VTEPS study, which examined thromboembolic events in a variety of plastic surgery procedures and concluded that postoperative, inpatient enoxaparin decreases 60-day rates of symptomatic thromboembolic events without significantly affecting hematoma rates. 67 To this end, although further research should examine approaches to preventing thromboembolic events in breast reconstruction patients, the limited evidence that does exist in this patient population is supported by the wider plastic surgery literature, which recommends the use of prophylactic postoperative enoxaparin.…”
Section: Rcsupporting
confidence: 70%
See 2 more Smart Citations